— Know what they know.
Not Investment Advice

KDMN NYSE

Kadmon Holdings, Inc.
1W: +0.4% 1M: +7.2% 3M: +88.5% 1Y: +197.8% 3Y: +257.1% 5Y: +104.3%
$9.50
Last traded 2021-11-08 — delisted
NYSE · Healthcare · Biotechnology

Cash Flow Trends

Operating Cash Flow
-$88M -9.3% ▼
Capital Expenditures
$443K +14.0% ▲
5Y CAGR: +22.4%
Free Cash Flow
-$88M -9.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$65M -245.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
— Operating Activities —
Net Income-$209M-$80M-$54M-$61M-$109M
Depreciation & Amort.$18M$2M$2M$2M$2M
Stock-Based Comp.$47M$12M$10M$7M$9M
Change in Working Capital$32M-$2M$62M$81M-$2M
Other Non-Cash Items$59M$4M-$90M-$109M$13M
Operating Cash Flow-$53M-$64M-$71M-$80M-$88M
— Investing Activities —
Capital Expenditures-$539K-$479K-$864K-$515K-$443K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0-$53M
Investment Sales$0$0$0$22M$22M
Other Investing$0$0$0$0$0
Investing Cash Flow-$539K-$479K-$864K$21M-$31M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$68M$96M$99M$103M$53M
Financing Cash Flow$68M$96M$99M$103M$53M
Net Change in Cash$15M$31M$27M$45M-$65M
Cash End of Period$36M$68M$97M$142M$77M
Free Cash Flow-$53M-$65M-$72M-$81M-$88M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms